Meropenem and Bleeding into the skin - a phase IV clinical study of FDA data

Summary:

Bleeding into the skin is reported as a side effect among people who take Meropenem (meropenem), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Diabetes.

The phase IV clinical study analyzes which people have Bleeding into the skin when taking Meropenem. It is created by eHealthMe based on reports of 33,250 people who have side effects when taking Meropenem from the FDA, and is updated regularly.

What is Meropenem?

Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.

What is Bleeding into the skin?

Bleeding into the skin is found to be associated with 937 drugs and 1,911 conditions by eHealthMe. Check the latest studies of Bleeding into the skin.

On Jul, 27, 2026

33,250 people reported to have side effects when taking Meropenem.
Among them, 82 people (0.25%) have Bleeding into the skin.

Could Meropenem cause Bleeding into the skin?

Among these 82 people:

How long have people been on Meropenem when they have Bleeding into the skin? *

What is the gender of people who have Bleeding into the skin when taking Meropenem? *

female: 50.63 %
male: 49.37 %

What is the age of people who have Bleeding into the skin when taking Meropenem? *

What are other drugs people take besides Meropenem? *

Vancomycin: 35 people, 42.68%
Paracetamol: 25 people, 30.49%
Dexamethasone: 12 people, 14.63%
Morphine: 12 people, 14.63%
Voriconazole: 11 people, 13.41%
Amlodipine: 11 people, 13.41%
Piperacillin And Tazobactam: 10 people, 12.20%
Metronidazole: 9 people, 10.98%
Cordarone: 8 people, 9.76%
Acetaminophen: 7 people, 8.54%

What are other side effects people have besides Bleeding into the skin? *

Rashes (redness): 29 people, 35.37%
Thrombocytopenia (decrease of platelets in blood): 24 people, 29.27%
Hypotension (abnormally low blood pressure): 21 people, 25.61%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 17 people, 20.73%
Fever: 17 people, 20.73%
Arrhythmias (irregular heartbeat): 14 people, 17.07%
Haemoglobin Decreased: 14 people, 17.07%
Acidosis (build-up of carbon dioxide in the blood): 11 people, 13.41%
Blood Creatinine Increased: 11 people, 13.41%
Hyperkalemia (damage to or disease of the kidney): 11 people, 13.41%

What are the existing conditions these people have? *

Diabetes: 13 people, 15.85%
Klebsiella Infection: 8 people, 9.76%
Endocarditis Bacterial (an inflammation of the inner layer of the heart by bacterial infection): 8 people, 9.76%
Pain: 7 people, 8.54%
Staphylococcal Infection (an infection with staphylococcus bacteria): 7 people, 8.54%
Proteus Infection (proteus can cause urinary tract infections): 5 people, 6.10%
Pneumonia: 5 people, 6.10%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 5 people, 6.10%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 6.10%
Iron Deficiency: 5 people, 6.10%

* Approximation only. Some reports may have incomplete information.

Do you take Meropenem and have Bleeding into the skin?

- Check whether Bleeding into the skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Meropenem:

Meropenem (33,295 reports)

Browse all side effects of Meropenem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding into the skin:

Bleeding into the skin (937 drugs)

Browse all the conditions that are associated with Bleeding into the skin:

Bleeding into the skin (1,911 conditions)

Related publications that referenced our studies

Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on meropenem (the active ingredients of Meropenem) and Meropenem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.